Moshe Oren
- Oncology top 0.01%
- Cancer-related Molecular Pathways 198
- Biotechnology top 0.01%
- Cancer Research and Treatments 75
- Cancer Research top 0.02%
- Molecular Biology top 0.02%
- RNA modifications and cancer 48
- Ubiquitin and proteasome pathways 47
- Epigenetics and DNA Methylation 45
- Cell death mechanisms and regulation 28
- RNA Research and Splicing 24
- Cell Biology top 0.1%
-
- Virus-based gene therapy research 34
- Co-authors
- Arnold J. LevineYgal HauptRuth MayaVarda RotterDan MichalovitzYaacov BarakDaniel EliyahuTanya Gottlieb
- Cited by
- OncologyBiotechnologyCancer Research
- Journals
- Molecular and Cellular Biology (35 papers)Oncogene (26 papers)Proceedings of the National Academy of Sciences (22 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Moshe Oren
323 papers receiving 47.7k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Oncology 28.8k
- Biotechnology 7.2k
- Cancer Research 9.9k
- Molecular Biology 34.9k
- Cell Biology 4.1k
Countries citing papers authored by Moshe Oren
This map shows the geographic impact of Moshe Oren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Oren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Oren more than expected).
Fields of papers citing papers by Moshe Oren
This network shows the impact of papers produced by Moshe Oren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Oren. The network helps show where Moshe Oren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Moshe Oren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 72 | |
| 4 | 2020 | 50 | |
| 5 | 2018 | 40 | |
| 6 | 2018 | 35 | |
| 7 | 2013 | 47 | |
| 8 | 2012 | 24 | |
| 9 | 2012 | 173 | |
| 10 | 2010 | 88 | |
| 11 | 2009 | 19 | |
| 12 | 2008 | 113 | |
| 13 | 2007 | 170 | |
| 14 | 2006 | 86 | |
| 15 | p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. | 1995 | 118 |
| 16 | 1992 | 105 | |
| 17 | 1989 | 16 | |
| 18 | 1988 | 283 | |
| 19 | 1984 | 15 | |
| 20 | 1983 | 98 |
About Moshe Oren
Moshe Oren is a scholar working on Biotechnology, Oncology, Cancer Research, Molecular Biology and Cell Biology, having authored 323 papers that have together received 48.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (198 papers), Cancer Research and Treatments (75 papers), RNA modifications and cancer (48 papers), Ubiquitin and proteasome pathways (47 papers), Epigenetics and DNA Methylation (45 papers), Virus-based gene therapy research (34 papers), Cell death mechanisms and regulation (28 papers) and RNA Research and Splicing (24 papers). The work is most often cited by research in Oncology (28.8k citations), Biotechnology (7.2k citations), Cancer Research (9.9k citations), Molecular Biology (34.9k citations) and Cell Biology (4.1k citations). Moshe Oren has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Arnold J. Levine, Ygal Haupt, Ruth Maya, Varda Rotter, Dan Michalovitz, Yaacov Barak, Daniel Eliyahu, Tanya Gottlieb, Dan Michael and Yael Aylon. Their work appears in journals such as Molecular and Cellular Biology, Oncogene, Proceedings of the National Academy of Sciences, Cell Death and Differentiation and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.